Patent · US Expired

β3 Adrenergic agonists

US7071208B2 · kind B2 · utility

2Cited by

4References

5Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Jolie Anne Bastian · Indianapolis, US
Gerd Ruehter · Hamburg, DE
Daniel Jon Sall · Greenwood, US
Theo Schotten · Winsen (Luhe), DE

Key dates

Filing date	Nov 12, 2002
Grant date	Jul 4, 2006
Priority date	—
Expiry date	Nov 12, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to a β3 adrenergic receptor agonist of formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.